BRÖSTCANCER - Karolinska Sjukhuset

1989
Fornander T, Rutqvist LE. Adjuvant tamoxifen and second cancers. Lancet 1989; 1: 616.
Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, et al. Adjuvant tamoxifen in early
breast cancer: occurrence of new primary cancers. Lancet 1989; 1: 117-20.
Harris BM, Eklund G, Meirik O, Rutqvist LE, Wiklund K. Risk of cancer of the breast after legal abortion
during first trimester: a Swedish register study. Bmj 1989; 299: 1430-2.
Nylen U, Baral E, Svane G, Rutqvist LE. Weekly doxorubicin in the treatment of metastatic breast carcinoma.
Acta Oncol 1989; 28: 515-7.
Rutqvist LE, Cedermark B, Fornander T, Glas U, Johansson H, Nordenskjold B, et al. The relationship between
hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer. J Clin Oncol
1989; 7: 1474-84.
Rutqvist LE, Cedermark B, Glas U, Johansson H, Rotstein S, Skoog L, et al. Radiotherapy, chemotherapy, and
tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials. Int J Radiat
Oncol Biol Phys 1989; 16: 629-39.
Stal O, Wingren S, Carstensen J, Rutqvist LE, Skoog L, Klintenberg C, et al. Prognostic value of DNA ploidy
and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary
breast cancer. Eur J Cancer Clin Oncol 1989; 25: 301-9.
Stanley MW, Tani EM, Rutqvist LE, Skoog L. Cystosarcoma phyllodes of the breast: a cytologic and
clinicopathologic study of 23 cases. Diagn Cytopathol 1989; 5: 29-34.
Wilking N, Rutqvist LE, Nordenskjold B, Skoog L. Steroid receptor levels in breast cancer. Relationships with
age and menopausal status. Acta Oncol 1989; 28: 807-10.
von Rosen A, Rutqvist LE, Carstensen J, Fallenius A, Skoog L, Auer G. Prognostic value of nuclear DNA
content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content. Breast
Cancer Res Treat 1989; 13: 23-32.
1990
Fornander T, Rutqvist LE, Sjoberg HE, Blomqvist L, Mattsson A, Glas U. Long-term adjuvant tamoxifen in
early breast cancer: effect on bone mineral density in postmenopausal women. J Clin Oncol 1990; 8:
1019-24.
Rutqvist LE. The significance of hormone receptors to predict the endocrine responsiveness of human breast
cancer. Acta Oncol 1990; 29: 371-7.
Rutqvist LE, Cedermark B, Glas U, Johansson H, Rotstein S, Skoog L, et al. Randomized trial of adjuvant
tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal
breast cancer. Cancer 1990; 66: 89-96.
Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients
from the Swedish Cancer Registry. Br J Cancer 1990; 61: 866-8.
Rutqvist LE, Miller AB, Andersson I, Hakama M, Hakulinen T, Sigfusson BF, et al. Reduced breast cancer
mortality with mammography screening--an assessment of currently available data. Int J Cancer Suppl
1990; 5: 76-84.
1991
Arriagada R, Rutqvist LE. Adjuvant chemotherapy in early breast cancer and incidence of new primary
malignancies. Lancet 1991; 338: 535-8.
Arriagada R, Rutqvist LE. Effect of lymph node irradiation in operable breast cancer. Cancer 1991; 68: 1859.
Arriagada R, Rutqvist LE. Lymph-node irradiation in operable breast cancer and statistical power. Eur J Cancer
1991; 27: 298.
Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjoden PO. Late effects of adjuvant chemotherapy and
postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 1991; 27: 1075-
81.
Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silfversward C. Prognostic factors in cystosarcoma phyllodes. A
clinicopathologic study of 77 patients. Cancer 1991; 68: 2017-22.
Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Skoog L, et al. Adjuvant tamoxifen in early-stage
breast cancer: effects on intercurrent morbidity and mortality. J Clin Oncol 1991; 9: 1740-8.
Fornander T, Rutqvist LE, Wilking N. Effects of tamoxifen on the female genital tract. Ann N Y Acad Sci 1991;
622: 469-76.
31